Martínez Osorio, C. A., Sopeña Sutil, R., Vilaseca Cabo, A., Linares Espinós, E., Ramírez Backhaus, M., Gómez Rivas, J., . . . de Pablos‐Rodríguez, P. (2025, September 4). Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide. The Prostate. https://doi.org/10.1002/pros.70040
Chicago Style (17th ed.) CitationMartínez Osorio, Christian Andrés, et al. "Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide." The Prostate 4 Sep. 2025. https://doi.org/10.1002/pros.70040.
MLA (9th ed.) CitationMartínez Osorio, Christian Andrés, et al. "Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide." The Prostate, 4 Sep. 2025, https://doi.org/10.1002/pros.70040.